BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

752 related articles for article (PubMed ID: 19846853)

  • 1. Atypical hemolytic-uremic syndrome.
    Noris M; Remuzzi G
    N Engl J Med; 2009 Oct; 361(17):1676-87. PubMed ID: 19846853
    [No Abstract]   [Full Text] [Related]  

  • 2. Atypical hemolytic uremic syndrome.
    Kavanagh D; Goodship TH; Richards A
    Semin Nephrol; 2013 Nov; 33(6):508-30. PubMed ID: 24161037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative complement pathway assessment in patients with atypical HUS.
    Roumenina LT; Loirat C; Dragon-Durey MA; Halbwachs-Mecarelli L; Sautes-Fridman C; Fremeaux-Bacchi V
    J Immunol Methods; 2011 Feb; 365(1-2):8-26. PubMed ID: 21215749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of defective complement control in hemolytic uremic syndrome.
    Zipfel PF; Misselwitz J; Licht C; Skerka C
    Semin Thromb Hemost; 2006 Mar; 32(2):146-54. PubMed ID: 16575689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome.
    Maga TK; Nishimura CJ; Weaver AE; Frees KL; Smith RJ
    Hum Mutat; 2010 Jun; 31(6):E1445-60. PubMed ID: 20513133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].
    Frémeaux-Bacchi V; Fakhouri F; Roumenina L; Dragon-Durey MA; Loirat C
    Rev Med Interne; 2011 Apr; 32(4):232-40. PubMed ID: 21376430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement dysfunction in hemolytic uremic syndrome.
    Zipfel PF; Skerka C
    Curr Opin Rheumatol; 2006 Sep; 18(5):548-55. PubMed ID: 16896298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on evaluating complement in hemolytic uremic syndrome.
    Kavanagh D; Goodship TH
    Curr Opin Nephrol Hypertens; 2007 Nov; 16(6):565-71. PubMed ID: 18089972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic abnormalities of complement regulators in hemolytic uremic syndrome: how do they affect patient management?
    Noris M; Remuzzi G
    Nat Clin Pract Nephrol; 2005 Nov; 1(1):2-3. PubMed ID: 16932353
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening for complement system abnormalities in patients with atypical hemolytic uremic syndrome.
    Kavanagh D; Richards A; Fremeaux-Bacchi V; Noris M; Goodship T; Remuzzi G; Atkinson JP
    Clin J Am Soc Nephrol; 2007 May; 2(3):591-6. PubMed ID: 17699467
    [No Abstract]   [Full Text] [Related]  

  • 11. Atypical hemolytic uremic syndrome associated with mutations in complement regulator genes.
    Le Quintrec M; Roumenina L; Noris M; Frémeaux-Bacchi V
    Semin Thromb Hemost; 2010 Sep; 36(6):641-52. PubMed ID: 20865641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics and complement in atypical HUS.
    Kavanagh D; Goodship T
    Pediatr Nephrol; 2010 Dec; 25(12):2431-42. PubMed ID: 20526633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement regulatory genes and hemolytic uremic syndromes.
    Kavanagh D; Richards A; Atkinson J
    Annu Rev Med; 2008; 59():293-309. PubMed ID: 17705684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in proteins of the alternative pathway of complement and the pathogenesis of atypical hemolytic uremic syndrome.
    Abarrategui-Garrido C; Melgosa M; Peña-Carrión A; de Jorge EG; de Córdoba SR; López-Trascasa M; Sánchez-Corral P
    Am J Kidney Dis; 2008 Jul; 52(1):171-80. PubMed ID: 18423815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete factor H deficiency-associated atypical hemolytic uremic syndrome in a neonate.
    Cho HY; Lee BS; Moon KC; Ha IS; Cheong HI; Choi Y
    Pediatr Nephrol; 2007 Jun; 22(6):874-80. PubMed ID: 17295030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantation in atypical hemolytic uremic syndrome.
    Kavanagh D; Richards A; Goodship T; Jalanko H
    Semin Thromb Hemost; 2010 Sep; 36(6):653-9. PubMed ID: 20865642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do complement factor H 402Y and C7 M allotypes predispose to (typical) haemolytic uraemic syndrome?
    Poolpol K; Gadner B; Neururer S; Mellmann A; Karch H; Orth D; Würzner R
    Int J Immunogenet; 2011 Oct; 38(5):383-7. PubMed ID: 21649859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in understanding the aetiology of atypical Haemolytic Uraemic Syndrome.
    Sánchez-Corral P; Melgosa M
    Br J Haematol; 2010 Sep; 150(5):529-42. PubMed ID: 20629662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel use of intravenous immunoglobulin is not restricted to complement hypercatabolism because of factor H deficiency.
    Späth PJ
    Prog Transplant; 2014 Jun; 24(2):120. PubMed ID: 24919726
    [No Abstract]   [Full Text] [Related]  

  • 20. [From gene to disease; the haemolytic uraemic syndrome can be caused by mutations in regulating factors of the alternative route of the complement system].
    Geelen JM; Klasen IS; van den Heuvel LP; Monnens LA
    Ned Tijdschr Geneeskd; 2007 Jan; 151(3):185-8. PubMed ID: 17288344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.